Use Repetitive Transcranial Magnetic Stimulation to Treat Somatic Symptom Disorder
Recruiting · NCT05161819 · Interventional (participants receive a specific treatment) · Lead sponsor: National Taiwan University Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Repetitive transcranial magnetic stimulationSham stimulation
What this trial is about
This is a randomized double-blind sham-controlled crossover study; the interventions are high-frequency rTMS stimulation on left DLPFC and sham control. The study population is the patient with somatic symptom disorder. The primary outcomes are somatic distress and health anxiety.
Who can take part
Age range
20 Years to 70 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patient with somatic symptom disorder (confirmed by psychiatrists)
- Age 20-70
Exclusion criteria
- Having psychotic symptoms or cognitive impairment
- Having potentially lethal illness
- Using cardiac pacemakers or defibrillators
- Currently pregnant or having plans to become pregnant within the next three months
- Received rTMS treatment within three months
- Cannot read the questionnaires by oneself
- Having to take the following medications persistently: bupropion \>300 mg/day、TCA、clozapine、chlorpromazine、foscarnet、ganciclovir、ritonavir、theophylline
Where it is running
1 location listed.
- National Taiwan University Hospital Yunlin Branch - Douliu, Yunlin, Taiwan